Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-16
DOI
10.1186/s12933-020-01066-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice
- (2019) Kentaro Mori et al. Cardiovascular Diabetology
- Vagus nerve stimulation exerts cardioprotection against myocardial ischemia/reperfusion injury predominantly through its efferent vagal fibers
- (2018) Watthana Nuntaphum et al. BASIC RESEARCH IN CARDIOLOGY
- Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
- (2018) Daisuke Matsutani et al. Cardiovascular Diabetology
- Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study
- (2018) Young-Gun Kim et al. Cardiovascular Diabetology
- Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
- (2018) Sarayut Lahnwong et al. Cardiovascular Diabetology
- Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2α-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy
- (2018) Hao Zhou et al. CELL DEATH AND DIFFERENTIATION
- Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
- (2018) Elisabetta Patorno et al. BMJ-British Medical Journal
- Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
- (2018) Elisabetta Patorno et al. BMJ-British Medical Journal
- Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
- (2018) Fumitaka Soga et al. Cardiovascular Diabetology
- Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
- (2017) Tsung-Ming Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target
- (2017) Alessandra Di Franco et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Emerging roles of sodium–glucose cotransporter 2 inhibitors in cardiology
- (2017) Atsushi Tanaka et al. Journal of Cardiology
- Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury
- (2017) Pongpan Tanajak et al. JOURNAL OF ENDOCRINOLOGY
- Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels
- (2016) Elisa Lucas et al. Cardiovascular Diabetology
- Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction
- (2016) Savitree Thummasorn et al. Cardiovascular Therapeutics
- Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
- (2016) Hiddo J.L. Heerspink et al. CIRCULATION
- SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
- (2016) Muhammad Abdul-Ghani et al. DIABETES CARE
- Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus
- (2016) Nikolaus Marx et al. EUROPEAN HEART JOURNAL
- Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats
- (2016) Pongpan Tanajak et al. JOURNAL OF ENDOCRINOLOGY
- Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats
- (2016) Wanpitak Pongkan et al. JOURNAL OF ENDOCRINOLOGY
- Sodium–glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis
- (2016) Harindra Rajasekeran et al. KIDNEY INTERNATIONAL
- Mitochondrial Dynamics in Diabetic Cardiomyopathy
- (2015) Chad A. Galloway et al. ANTIOXIDANTS & REDOX SIGNALING
- Inhibition of the Mitochondrial Fission Protein Dynamin-Related Protein 1 Improves Survival in a Murine Cardiac Arrest Model
- (2015) Willard W. Sharp et al. CRITICAL CARE MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Testosterone Replacement Exerts Cardioprotection against Cardiac Ischemia-Reperfusion Injury by Attenuating Mitochondrial Dysfunction in Testosterone-Deprived Rats
- (2015) Wanpitak Pongkan et al. PLoS One
- Epidemiological studies of CHD and the evolution of preventive cardiology
- (2014) Nathan D. Wong Nature Reviews Cardiology
- Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia–reperfusion rat heart
- (2013) Kroekkiat Chinda et al. Diabetes & Vascular Disease Research
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target
- (2013) Derek J. Hausenloy et al. JOURNAL OF CLINICAL INVESTIGATION
- The Lambeth Conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias
- (2013) Michael J. Curtis et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of p38 MAPK During Ischemia, But Not Reperfusion, Effectively Attenuates Fatal Arrhythmia in Ischemia/Reperfusion Heart
- (2012) Sirirat Surinkaew et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Mitochondrial Fission, Fusion, and Stress
- (2012) R. J. Youle et al. SCIENCE
- Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria
- (2011) Savitree Thummasorn et al. MITOCHONDRION
- Peroxisome Proliferator Activated Receptor-Alpha (PPARα) and PPAR Gamma Coactivator-1alpha (PGC-1α) Regulation of Cardiac Metabolism in Diabetes
- (2011) Jennifer G. Duncan PEDIATRIC CARDIOLOGY
- Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury
- (2010) Sang-Bing Ong et al. CIRCULATION
- Distribution of coronary atherosclerosis in patients with coronary artery disease
- (2010) Kohichiro Iwasaki et al. HEART AND VESSELS
- Mitochondrial fusion and fission in cell life and death
- (2010) Benedikt Westermann NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Systems of Care for ST-Segment Elevation Myocardial Infarction
- (2009) Nicolas Danchin JACC-Cardiovascular Interventions
- Chronic Coronary Artery Disease: Diagnosis and Management
- (2009) Andrew Cassar et al. MAYO CLINIC PROCEEDINGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now